Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 26
Phase 34

Trial Status

Completed9
Other3

Role Distribution

Principal Investigator12
PI Rate100%

Activity Timeline

Clinical Trials (12)

NCT04647695Phase 2Unknown
IFN-beta 1b and Remdesivir for COVID19
Covid19
PrincipalinvestigatorStart date: 2020-11-20
NCT04494399Phase 2Unknown
IFN Beta-1b and Ribavirin for Covid-19
Covid19
PrincipalinvestigatorStart date: 2020-07-29
NCT04350281Phase 2Completed
Double Therapy With IFN-beta 1b and Hydroxychloroquine
COVID
PrincipalinvestigatorStart date: 2020-04-09
NCT04276688Phase 2Completed
Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment
Novel Coronavirus Infection
PrincipalinvestigatorStart date: 2020-02-10
NCT02329457Phase 2/3Completed
VZV Vaccine for Hematopoietic Stem Cell Transplantation
Varicella Zoster Infection
PrincipalinvestigatorStart date: 2014-12-01
NCT02108366Phase 3Completed
Treatment of Severe Influenza A Infection
Influenza, Human
PrincipalinvestigatorStart date: 2014-03-01
NCT01306773Not ApplicableCompleted
Convalescent Plasma Treatment in Severe 2009 H1N1 Infection
Influenza A
Principalinvestigator
NCT01508884Not ApplicableCompleted
Intradermal Trivalent Influenza Vaccine With Imiquimod
Chronic Illness
Principalinvestigator
NCT01617317Not ApplicableCompleted
H-IVIG Treatment for Severe H1N1 2009
Novel 2009 Influenza A (H1N1) Infection
Principalinvestigator

Showing 10 of 12 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (12)

Showing 12 of 12 trials

NCT04647695Phase 2PrincipalInvestigator

IFN-beta 1b and Remdesivir for COVID19

Covid19
Unknown
NCT04494399Phase 2PrincipalInvestigator

IFN Beta-1b and Ribavirin for Covid-19

Covid19
Unknown
NCT04350281Phase 2PrincipalInvestigator

Double Therapy With IFN-beta 1b and Hydroxychloroquine

COVID
Completed
NCT04276688Phase 2PrincipalInvestigator

Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment

Novel Coronavirus Infection
Completed
NCT04143451Phase 3PrincipalInvestigator

Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients

Influenza
Unknown
NCT02329457Phase 2/3PrincipalInvestigator

VZV Vaccine for Hematopoietic Stem Cell Transplantation

Varicella Zoster Infection
Completed
NCT02108366Phase 3PrincipalInvestigator

Treatment of Severe Influenza A Infection

Influenza, Human
Completed
NCT01306773Not ApplicablePrincipalInvestigator

Convalescent Plasma Treatment in Severe 2009 H1N1 Infection

Influenza A
Completed
NCT01508884Not ApplicablePrincipalInvestigator

Intradermal Trivalent Influenza Vaccine With Imiquimod

Chronic Illness
Completed
NCT01617317Not ApplicablePrincipalInvestigator

H-IVIG Treatment for Severe H1N1 2009

Novel 2009 Influenza A (H1N1) Infection
Completed
NCT01760824Not ApplicablePrincipalInvestigator

Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication

Helicobacter Pylori Infection
Completed
NCT02621112Phase 2/3PrincipalInvestigator

HBV Vaccine in Renal Failure Patients

Renal Failure
Completed

All 12 trials loaded